US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Leo Pharma Sues Perrigo Israel Over Generic Taclonex

By Dan Rivoli · February 16, 2011, 5:18 PM EST

Leo Pharma A/S has sued generic-drug maker Perrigo Israel Pharmaceuticals Ltd. to block it from selling its own version of the Danish company's Taclonex ointment, used to treat the skin disease...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Leo Pharma A/S v. Perrigo Isrel Pharma Ltd.

Case Number

1:11-cv-00963

Court

New York Southern

Nature of Suit

Patent

Date Filed

February 14, 2011

Featured Stories

What's Next After High Court's Medicare Drug Pricing Pass No Photo Available

Yeji Jesse Lee

As the pharmaceutical industry grapples with the U.S. Supreme Court's refusal to hear about the legality of Medicare drug pricing nego... (more story)

New Suits Target Fed. Loan Rule, CVS 340B Rates And More No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at new lawsuits targeting a U.S. Department of Education rule limiting loans available to students i... (more story)

Justice Alito Calls Out Slow Pace Of FDA Mifepristone Study No Photo Available

Dan McKay

The Trump administration’s slow-paced review of the abortion medication mifepristone has the attention of a U.S. Supreme Court justice... (more story)